Skin Laboratory PCL (BKK:SKIN)
Thailand
· Delayed Price · Currency is THB 1.100
0.00 (0.00%)
At close: Apr 28, 2026
Skin Laboratory PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Market Capitalization | 158 | 194 | - | - | - | - | Upgrade
|
| Enterprise Value | 82 | 116 | - | - | - | - | Upgrade
|
| Last Close Price | 1.10 | 1.35 | - | - | - | - | Upgrade
|
| PE Ratio | 28.31 | 44.41 | - | - | - | - | Upgrade
|
| PS Ratio | 0.89 | 1.09 | - | - | - | - | Upgrade
|
| PB Ratio | 1.57 | 1.92 | - | - | - | - | Upgrade
|
| P/TBV Ratio | 1.57 | 1.93 | - | - | - | - | Upgrade
|
| P/FCF Ratio | 13.23 | 16.24 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 12.71 | 15.60 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 0.46 | 0.65 | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 11.01 | 18.78 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 14.29 | 20.27 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 6.86 | 9.73 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.06 | 0.05 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.19 | 0.19 | 0.17 | 0.20 | 0.22 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.12 | 0.12 | 0.75 | 0.17 | 0.77 | 0.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.75 | -0.75 | -0.44 | -0.63 | -0.48 | -0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | -12.30 | -12.30 | -1.88 | -2.09 | -2.21 | -1.14 | Upgrade
|
| Net Debt / FCF Ratio | -6.38 | -6.38 | -7.59 | -1.72 | -7.46 | -3.88 | Upgrade
|
| Asset Turnover | 1.72 | 1.72 | 2.43 | 2.64 | 2.76 | 1.89 | Upgrade
|
| Inventory Turnover | 2.57 | 2.57 | 3.05 | 3.08 | 2.79 | 3.01 | Upgrade
|
| Quick Ratio | 5.10 | 5.10 | 2.91 | 2.74 | 2.71 | 3.15 | Upgrade
|
| Current Ratio | 6.15 | 6.15 | 3.91 | 3.42 | 3.58 | 4.46 | Upgrade
|
| Return on Equity (ROE) | 5.38% | 5.38% | 15.95% | 23.37% | 15.83% | 40.76% | Upgrade
|
| Return on Assets (ROA) | 3.44% | 3.44% | 8.90% | 12.88% | 9.26% | 21.79% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.93% | 15.13% | 34.65% | 52.98% | 32.78% | 107.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.50% | 5.50% | 20.60% | 27.70% | 20.10% | 44.90% | Upgrade
|
| Earnings Yield | 2.76% | 2.25% | - | - | - | - | Upgrade
|
| FCF Yield | 7.56% | 6.16% | - | - | - | - | Upgrade
|
| Payout Ratio | 376.89% | 376.89% | 656.07% | 95.31% | 110.21% | 46.92% | Upgrade
|
| Buyback Yield / Dilution | -162.19% | -162.19% | -2048.36% | - | - | - | Upgrade
|
| Total Shareholder Return | -162.19% | -162.19% | -2048.36% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.